サンプル依頼リスト カート
  • English
  • Korean
表紙：ゾリンジャーエリソン症候群治療の世界市場レポート 2024年
市場調査レポート
商品コード
1415750

ゾリンジャーエリソン症候群治療の世界市場レポート 2024年

Zollinger-Ellison Syndrome Treatment Global Market Report 2024
出版日: 受注後更新 | 発行: The Business Research Company | ページ情報: 英文 175 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
ゾリンジャーエリソン症候群治療の世界市場レポート 2024年
出版日: 受注後更新
発行: The Business Research Company
ページ情報: 英文 175 Pages
納期: 2～10営業日
  • 全表示
  • 概要
  • 目次
概要

ゾリンジャーエリソン症候群治療の市場規模は近年力強く成長しています。2023年の12億8,000万米ドルから2024年には13億5,000万米ドルに、CAGR5.3％で拡大します。実績期間の成長は、消化器病学の進歩、Zesの罹患率の増加、集学的ケアチーム、長期モニタリングに起因しています。

ゾリンジャーエリソン症候群治療の市場規模は、今後数年間で安定した成長が見込まれます。2028年には年間平均成長率（CAGR）4.8％で16億3,000万米ドルに成長します。予測期間の成長は、世界のヘルスケアアクセス、遺伝子スクリーニングと診断、個別化された治療計画、規制の変更、償還政策に起因すると考えられます。予測期間の主な動向には、高度な画像診断・診断ツール、オーダーメイド薬、患者中心のケア、低侵襲的介入などが含まれます。

消化器疾患の罹患率の増加は、当面のゾリンジャーエリソン症候群治療市場の拡大を牽引すると予測されます。消化器疾患には、食物の分解と栄養吸収を担う消化器系の正常な機能を阻害するさまざまな疾患が含まれます。ゾリンジャー・エリソン症候群（ZES）治療は、消化性潰瘍疾患や胃食道逆流症（GERD）などの消化器疾患の管理に用いられます。この治療は主に胃酸の分泌を抑えることに重点を置いており、消化性潰瘍や胃酸逆流に伴う合併症の予防と治療に役立ちます。一例として、2022年8月に国立医学図書館が発表したデータによると、消化性潰瘍疾患（PUD）は全世界で年間400万人が罹患しており、一般人口の生涯有病率は5～10％と推定されています。さらに、毎年6,200万人のアメリカ人が様々な消化器疾患と診断されています。その結果、消化器疾患の有病率の上昇がゾリンジャーエリソン症候群治療市場の原動力になると予想されます。

非侵襲的診断処置のニーズの高まりが、今後ゾリンジャーエリソン症候群治療市場の成長を促進すると予測されています。非侵襲的診断手順には、自然または人工的な開口部を通じて身体に物理的に侵入する必要のない医療評価や治療が含まれます。非侵襲的診断手順は、ゾリンジャー・エリソン症候群の早期発見を容易にし、迅速な治療と転帰の改善につながります。例えば、2022年8月のDefinitive Healthcare LLCの報告書によると、2021年に最も多く実施された非侵襲的血管検査手技の1つで、実施された手技は267万件で、四肢静脈の制限または片側デュプレックススキャンでした。四肢静脈の両側デュプレックススキャンは第2位で、2021年には216万件以上の手技が行われました。したがって、非侵襲的診断手技に対する需要の高まりが、ゾリンジャーエリソン症候群治療市場の成長の触媒となっています。

2023年のゾリンジャーエリソン症候群治療市場で最大の地域は北米でした。ゾリンジャーエリソン症候群治療レポートの対象地域は、アジア太平洋、西欧、中東欧、北米、南米、中東およびアフリカです。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 マクロ経済シナリオ

  • 高インフレが市場に与える影響
  • ウクライナ・ロシア戦争が市場に与える影響
  • COVID-19による市場への影響

第5章 世界市場規模と成長

  • 世界の市場促進要因と抑制要因
    • 市場促進要因
    • 市場抑制要因
  • 世界の市場規模実績と成長、2018年～2023年
  • 世界の市場規模予測と成長、2023年～2028年、2033年

第6章 市場セグメンテーション

  • 世界のゾリンジャーエリソン症候群治療市場、診断別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • 血液検査
  • CTスキャン超音波検査
  • X線
  • その他の診断
  • 世界のゾリンジャーエリソン症候群治療市場、治療別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • 化学療法
  • 外科的切除
  • その他の治療
  • 世界のゾリンジャーエリソン症候群治療市場、流通チャネル別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • 病院薬局
  • 小売薬局
  • オンライン薬局
  • その他の流通チャネル
  • 世界のゾリンジャーエリソン症候群治療市場、エンドユーザー別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • 病院
  • 専門クリニック
  • その他のエンドユーザー

第7章 地域および国の分析

  • 世界のゾリンジャーエリソン症候群治療市場、地域別、実績および予測、2018-2023年、2023-2028年、2033年
  • 世界のゾリンジャーエリソン症候群治療市場、国別、実績および予測、2018-2023年、2023-2028年、2033年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

  • ゾリンジャーエリソン症候群治療市場の競合情勢
  • ゾリンジャーエリソン症候群治療市場の企業プロファイル
    • Pfizer Inc.
    • F. Hoffmann-La Roche Ltd.
    • Merck &Co. Inc.
    • Bayer AG
    • Novartis AG

第31章 その他の主要および革新的な企業

  • Sanofi S.A.
  • AstraZeneca PLC
  • Abbott Laboratories
  • GSK PLC
  • Takeda Pharmaceutical Company Limited
  • Eli Lilly and Company
  • Viatris Inc.
  • Teva Pharmaceutical Industries Ltd.
  • Daiichi Sankyo Company Limited
  • Shionogi & Company Limited
  • Cipla Limited
  • Aurobindo Pharma Ltd.
  • Dr. Reddy's Laboratories Ltd.
  • Apotex Inc.
  • Hikma Pharmaceuticals PLC

第32章 競合ベンチマーキング

第33章 競合ダッシュボード

第34章 主要な合併と買収

第35章 将来の見通しと可能性の分析

第36章 付録

目次
Product Code: r12349

“Zollinger-Ellison Syndrome Treatment Global Market Report 2024 ” from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on zollinger-ellison syndrome treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for zollinger-ellison syndrome treatment? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? “The zollinger-ellison syndrome treatment market global report ” from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

Scope

Markets Covered:

  • 1) By Diagnosis: Blood Test; CT Scan Ultrasound; X-Ray; Other Diagnosis
  • 2) By Treatment: Chemotherapy; Surgical Resection; Other Treatments
  • 3) By Distribution Channel: Hospital Pharmacy; Retail Pharmacy; Online Pharmacies; Other Distribution Channels
  • 4) By End User: Hospitals; Specialty Clinics; Other End Users
  • Companies Mentioned: Pfizer Inc.; F. Hoffmann-La Roche Ltd.; Merck & Co. Inc.; Bayer AG; Novartis AG
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Executive Summary

Zollinger-Ellison syndrome is a rare condition characterized by the presence of gastrin-secreting tumors in either the pancreas or the duodenum, leading to excessive production of stomach acid. The primary goal of treating Zollinger-Ellison syndrome is to manage the overproduction of stomach acid, alleviate symptoms, and address any complications associated with the disorder. This treatment approach encompasses medical management, surgical interventions, and ongoing monitoring.

Diagnosing Zollinger-Ellison syndrome involves a range of tests, including blood tests, CT scans, ultrasounds, X-rays, and other diagnostic methods. Blood tests, also referred to as blood analyses or blood work, are medical procedures employed to collect and analyze blood samples from patients. The treatment options for Zollinger-Ellison syndrome encompass various modalities, including chemotherapy, surgical resection, and other therapeutic approaches. These treatments are available through multiple distribution channels, such as hospital pharmacies, retail pharmacies, online pharmacies, and others, and are utilized by various end users, including hospitals, specialty clinics, and other healthcare facilities.

The zollinger-ellison syndrome treatment market research report is one of a series of new reports from The Business Research Company that provides zollinger-ellison syndrome treatment market statistics, including zollinger-ellison syndrome treatment industry global market size, regional shares, competitors with a zollinger-ellison syndrome treatment market share, detailed zollinger-ellison syndrome treatment market segments, market trends and opportunities and any further data you may need to thrive in the zollinger-ellison syndrome treatment industry. This zollinger-ellison syndrome treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The zollinger-ellison syndrome treatment market size has grown strongly in recent years. It will grow from $1.28 billion in 2023 to $1.35 billion in 2024 at a compound annual growth rate (CAGR) of 5.3%. The growth in the historic period can be attributed to advancements in gastroenterology, increased incidence of zes, multidisciplinary care teams, long-term monitoring.

The zollinger-ellison syndrome treatment market size is expected to see steady growth in the next few years. It will grow to $1.63 billion in 2028 at a compound annual growth rate (CAGR) of 4.8%. The growth in the forecast period can be attributed to global healthcare access, genetic screening and diagnosis, personalized treatment plans, regulatory changes and reimbursement policies. Major trends in the forecast period include advanced imaging and diagnostic tools, tailored medications, patient-centered care, minimally invasive interventions.

The growing incidence of digestive disorders is anticipated to drive the expansion of the Zollinger-Ellison syndrome treatment market in the foreseeable future. Digestive disorders encompass a range of conditions that disrupt the normal functioning of the digestive system, responsible for food breakdown and nutrient absorption. Zollinger-Ellison syndrome (ZES) treatment is employed to manage digestive disorders such as peptic ulcer disease and gastroesophageal reflux disease (GERD). The treatment primarily focuses on reducing stomach acid production, which can aid in the prevention and treatment of complications associated with peptic ulcers or acid reflux. As an example, data from the National Library of Medicine in August 2022 revealed that peptic ulcer disease (PUD) affects four million individuals globally annually, with an estimated lifetime prevalence of 5-10% among the general population. Furthermore, each year, 62 million Americans are diagnosed with various digestive disorders. Consequently, the rising prevalence of digestive disorders is expected to be a driving force for the Zollinger-Ellison syndrome treatment market.

The growing need for non-invasive diagnostic procedures is projected to foster the growth of the Zollinger-Ellison syndrome treatment market in the coming period. Non-invasive diagnostic procedures encompass medical assessments and treatments that do not require physical penetration of the body through natural or artificial openings, or the breaking of the skin. Non-invasive diagnostic procedures can facilitate the early detection of Zollinger-Ellison Syndrome, leading to prompt treatment and improved outcomes. For instance, according to a report by Definitive Healthcare LLC in August 2022, one of the most commonly performed non-invasive vascular study procedures in 2021, with 2.67 million procedures conducted, was the restricted or unilateral duplex scan of extremity veins. The total bilateral duplex scan of extremity veins came second, with over 2.16 million procedures completed in 2021. Hence, the increasing demand for non-invasive diagnostic procedures is a catalyst for the growth of the Zollinger-Ellison syndrome treatment market.

The presence of medication side effects is projected to pose challenges to the growth of the Zollinger-Ellison syndrome treatment market. Medication side effects pertain to unintended and often undesirable outcomes that can occur when individuals take medications to address medical conditions. In the context of Zollinger-Ellison Syndrome (ZES), medications like proton pump inhibitors (PPIs), which are used to manage excessive stomach acid in ZES patients, may lead to side effects such as headaches, diarrhea, and stomach discomfort. Consequently, these medication-related side effects are impeding the growth of the Zollinger-Ellison syndrome treatment market.

Major players within the Zollinger-Ellison syndrome treatment market are dedicated to pioneering new drugs and securing their approvals to bolster their market positions. Existing treatments for ZES can carry significant side effects, including the potential for renal and liver damage. Advanced treatments have the potential to mitigate the adverse effects associated with traditional medications and enhance patient outcomes. For instance, in May 2023, Meitheal Pharmaceuticals Inc., a U.S.-based manufacturer of generic injectable products, introduced Pantoprazole Sodium for Injection at 40 mg per vial. This proton pump inhibitor (PPI) is recommended for individuals with pathological hypersecretory conditions like Zollinger-Ellison (ZE) Syndrome. It works by inhibiting the proton pump enzyme (H+/K+ ATPase) in gastric parietal cells, thereby reducing stomach acid secretion and alleviating ZE syndrome-related symptoms.

In June 2023, Ironwood Pharmaceuticals, a U.S.-based healthcare company with a focus on gastrointestinal (GI) conditions, acquired VectivBio for an estimated $1 billion. This strategic acquisition is poised to strengthen Ironwood's innovation pipeline and portfolio, with the aim of redefining the standard of care for GI patients and advancing the treatment of GI disorders. VectivBio, based in Switzerland, specializes in offering treatments for severe rare gastrointestinal conditions, including ZES.

Major players in the zollinger-ellison syndrome treatment market are Pfizer Inc., F. Hoffmann-La Roche Ltd., Merck & Co. Inc., Bayer AG, Novartis AG, Sanofi S.A., AstraZeneca PLC, Abbott Laboratories, GSK PLC, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Viatris Inc., Teva Pharmaceutical Industries Ltd., Daiichi Sankyo Company Limited, Shionogi & Company Limited, Cipla Limited, Aurobindo Pharma Ltd., Dr. Reddy's Laboratories Ltd., Apotex Inc., Hikma Pharmaceuticals PLC, Lupin Limited, Zydus Lifesciences Limited, Glenmark Pharmaceuticals Ltd., Alkem Laboratories, Accord Healthcare Limited, Ordain Health Care Global Pvt.Ltd., Alembic Pharmaceuticals Ltd., Wockhardt Ltd., Biochem Pharmaceuticals Industries Limited .

North America was the largest region in the zollinger-ellison syndrome treatment market in 2023. The regions covered in zollinger-ellison syndrome treatment report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the zollinger-ellison syndrome treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The zollinger-ellison syndrome treatment market consists of revenues earned by entities by providing surgical removal of tumors and gastrin level monitoring. The market value includes the value of related goods sold by the service provider or included within the service offering. The Zollinger-Ellison syndrome treatment market also includes sales of somatostatin analogs, proton pump inhibitors (PPIs) and gastrin inhibitors. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Table of Contents

1. Executive Summary

2. Zollinger-Ellison Syndrome Treatment Market Characteristics

3. Zollinger-Ellison Syndrome Treatment Market Trends And Strategies

4. Zollinger-Ellison Syndrome Treatment Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global Zollinger-Ellison Syndrome Treatment Market Size and Growth

  • 5.1. Global Zollinger-Ellison Syndrome Treatment Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Zollinger-Ellison Syndrome Treatment Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Zollinger-Ellison Syndrome Treatment Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Zollinger-Ellison Syndrome Treatment Market Segmentation

  • 6.1. Global Zollinger-Ellison Syndrome Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Blood Test
  • CT Scan Ultrasound
  • X-Ray
  • Other Diagnosis
  • 6.2. Global Zollinger-Ellison Syndrome Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Chemotherapy
  • Surgical Resection
  • Other Treatments
  • 6.3. Global Zollinger-Ellison Syndrome Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Pharmacies
  • Other Distribution Channels
  • 6.4. Global Zollinger-Ellison Syndrome Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Hospitals
  • Specialty Clinics
  • Other End Users

7. Zollinger-Ellison Syndrome Treatment Market Regional And Country Analysis

  • 7.1. Global Zollinger-Ellison Syndrome Treatment Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Zollinger-Ellison Syndrome Treatment Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Zollinger-Ellison Syndrome Treatment Market

  • 8.1. Asia-Pacific Zollinger-Ellison Syndrome Treatment Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Zollinger-Ellison Syndrome Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Zollinger-Ellison Syndrome Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Zollinger-Ellison Syndrome Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Zollinger-Ellison Syndrome Treatment Market

  • 9.1. China Zollinger-Ellison Syndrome Treatment Market Overview
  • 9.2. China Zollinger-Ellison Syndrome Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Zollinger-Ellison Syndrome Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Zollinger-Ellison Syndrome Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Zollinger-Ellison Syndrome Treatment Market

  • 10.1. India Zollinger-Ellison Syndrome Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Zollinger-Ellison Syndrome Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Zollinger-Ellison Syndrome Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Zollinger-Ellison Syndrome Treatment Market

  • 11.1. Japan Zollinger-Ellison Syndrome Treatment Market Overview
  • 11.2. Japan Zollinger-Ellison Syndrome Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Zollinger-Ellison Syndrome Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Zollinger-Ellison Syndrome Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Zollinger-Ellison Syndrome Treatment Market

  • 12.1. Australia Zollinger-Ellison Syndrome Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Zollinger-Ellison Syndrome Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Zollinger-Ellison Syndrome Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Zollinger-Ellison Syndrome Treatment Market

  • 13.1. Indonesia Zollinger-Ellison Syndrome Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Zollinger-Ellison Syndrome Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Zollinger-Ellison Syndrome Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Zollinger-Ellison Syndrome Treatment Market

  • 14.1. South Korea Zollinger-Ellison Syndrome Treatment Market Overview
  • 14.2. South Korea Zollinger-Ellison Syndrome Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Zollinger-Ellison Syndrome Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Zollinger-Ellison Syndrome Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Zollinger-Ellison Syndrome Treatment Market

  • 15.1. Western Europe Zollinger-Ellison Syndrome Treatment Market Overview
  • 15.2. Western Europe Zollinger-Ellison Syndrome Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Zollinger-Ellison Syndrome Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Zollinger-Ellison Syndrome Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Zollinger-Ellison Syndrome Treatment Market

  • 16.1. UK Zollinger-Ellison Syndrome Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Zollinger-Ellison Syndrome Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Zollinger-Ellison Syndrome Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Zollinger-Ellison Syndrome Treatment Market

  • 17.1. Germany Zollinger-Ellison Syndrome Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Zollinger-Ellison Syndrome Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Zollinger-Ellison Syndrome Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Zollinger-Ellison Syndrome Treatment Market

  • 18.1. France Zollinger-Ellison Syndrome Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France Zollinger-Ellison Syndrome Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France Zollinger-Ellison Syndrome Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Zollinger-Ellison Syndrome Treatment Market

  • 19.1. Italy Zollinger-Ellison Syndrome Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy Zollinger-Ellison Syndrome Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy Zollinger-Ellison Syndrome Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Zollinger-Ellison Syndrome Treatment Market

  • 20.1. Spain Zollinger-Ellison Syndrome Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain Zollinger-Ellison Syndrome Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain Zollinger-Ellison Syndrome Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Zollinger-Ellison Syndrome Treatment Market

  • 21.1. Eastern Europe Zollinger-Ellison Syndrome Treatment Market Overview
  • 21.2. Eastern Europe Zollinger-Ellison Syndrome Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Zollinger-Ellison Syndrome Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Zollinger-Ellison Syndrome Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Zollinger-Ellison Syndrome Treatment Market

  • 22.1. Russia Zollinger-Ellison Syndrome Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Zollinger-Ellison Syndrome Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Zollinger-Ellison Syndrome Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Zollinger-Ellison Syndrome Treatment Market

  • 23.1. North America Zollinger-Ellison Syndrome Treatment Market Overview
  • 23.2. North America Zollinger-Ellison Syndrome Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Zollinger-Ellison Syndrome Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Zollinger-Ellison Syndrome Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Zollinger-Ellison Syndrome Treatment Market

  • 24.1. USA Zollinger-Ellison Syndrome Treatment Market Overview
  • 24.2. USA Zollinger-Ellison Syndrome Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Zollinger-Ellison Syndrome Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Zollinger-Ellison Syndrome Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Zollinger-Ellison Syndrome Treatment Market

  • 25.1. Canada Zollinger-Ellison Syndrome Treatment Market Overview
  • 25.2. Canada Zollinger-Ellison Syndrome Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Zollinger-Ellison Syndrome Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Zollinger-Ellison Syndrome Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Zollinger-Ellison Syndrome Treatment Market

  • 26.1. South America Zollinger-Ellison Syndrome Treatment Market Overview
  • 26.2. South America Zollinger-Ellison Syndrome Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Zollinger-Ellison Syndrome Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Zollinger-Ellison Syndrome Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Zollinger-Ellison Syndrome Treatment Market

  • 27.1. Brazil Zollinger-Ellison Syndrome Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Zollinger-Ellison Syndrome Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Zollinger-Ellison Syndrome Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Zollinger-Ellison Syndrome Treatment Market

  • 28.1. Middle East Zollinger-Ellison Syndrome Treatment Market Overview
  • 28.2. Middle East Zollinger-Ellison Syndrome Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Zollinger-Ellison Syndrome Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Zollinger-Ellison Syndrome Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Zollinger-Ellison Syndrome Treatment Market

  • 29.1. Africa Zollinger-Ellison Syndrome Treatment Market Overview
  • 29.2. Africa Zollinger-Ellison Syndrome Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Zollinger-Ellison Syndrome Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Zollinger-Ellison Syndrome Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Zollinger-Ellison Syndrome Treatment Market Competitive Landscape And Company Profiles

  • 30.1. Zollinger-Ellison Syndrome Treatment Market Competitive Landscape
  • 30.2. Zollinger-Ellison Syndrome Treatment Market Company Profiles
    • 30.2.1. Pfizer Inc.
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. F. Hoffmann-La Roche Ltd.
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. Merck & Co. Inc.
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. Bayer AG
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. Novartis AG
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Zollinger-Ellison Syndrome Treatment Market Other Major And Innovative Companies

  • 31.1. Sanofi S.A.
  • 31.2. AstraZeneca PLC
  • 31.3. Abbott Laboratories
  • 31.4. GSK PLC
  • 31.5. Takeda Pharmaceutical Company Limited
  • 31.6. Eli Lilly and Company
  • 31.7. Viatris Inc.
  • 31.8. Teva Pharmaceutical Industries Ltd.
  • 31.9. Daiichi Sankyo Company Limited
  • 31.10. Shionogi & Company Limited
  • 31.11. Cipla Limited
  • 31.12. Aurobindo Pharma Ltd.
  • 31.13. Dr. Reddy's Laboratories Ltd.
  • 31.14. Apotex Inc.
  • 31.15. Hikma Pharmaceuticals PLC

32. Global Zollinger-Ellison Syndrome Treatment Market Competitive Benchmarking

33. Global Zollinger-Ellison Syndrome Treatment Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Zollinger-Ellison Syndrome Treatment Market

35. Zollinger-Ellison Syndrome Treatment Market Future Outlook and Potential Analysis

  • 35.1 Zollinger-Ellison Syndrome Treatment Market In 2028 - Countries Offering Most New Opportunities
  • 35.2 Zollinger-Ellison Syndrome Treatment Market In 2028 - Segments Offering Most New Opportunities
  • 35.3 Zollinger-Ellison Syndrome Treatment Market In 2028 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer